Drug recall

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus…

FDA recall event 96433 · Class II · Slate Run Pharmaceuticals

Key facts

Event ID 96433
Recall numbers D-0278-2025, D-0279-2025
Recalling firm Slate Run Pharmaceuticals
Product type Drugs
Products Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04, Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04
Classification Class II
Status Ongoing
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Initiation date Mar 7, 2025
Report date Mar 26, 2025
City Columbus
State OH
Country United States
FEI number 3012729077

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls